Nitric oxide in upper airways inflammatory diseases


In the human respiratory tract, the main production sites of exhaled nitric oxide (NO) are the nose and paranasal sinuses. In the upper airways, NO has been suggested to be involved at different levels with regulatory, protective, defensive or deleterious effects. Therefore, we review some aspects of the origin, metabolism, and functions of NO in the upper airways, together with the role of NO in some upper airways inflammatory diseases. Furthermore, we discuss the recent improvements in nasal NO measurements, which may be useful to better characterize the involvement of the NO produced by nose and paranasal sinuses in upper airways inflammatory diseases such as allergic rhinitis, nasal polyposis, sinusitis, primary ciliary dyskinesia, and cystic fibrosis.

This is a preview of subscription content, log in to check access.

Author information



Corresponding author

Correspondence to M. Maniscalco.

Additional information

Received 9 May 2006; returned for revision 19 June 2006; accepted by M. Parnham 21 September 2006

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Maniscalco, M., Sofia, M. & Pelaia, G. Nitric oxide in upper airways inflammatory diseases. Inflamm. res. 56, 58–69 (2007).

Download citation


  • Asthma
  • PCD
  • Cystic fibrosis
  • Humming
  • Polyposis
  • Rhinitis
  • Sinusitis